Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The Retinoblastoma Gene

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Response Regarding: RECIST Responses to Radiation in Retroperitoneal Soft Tissue Sarcoma: When and How Often Do They Occur?

The Journal of surgical research·2026

Same author

Pathologic Response and Outcomes After Neoadjuvant Chemotherapy in Gastric Cancer: A NCDB Analysis.

Journal of surgical oncology·2026

Same author

Redefining the Lymphadenectomy Standard to Avoid Understaging in Oncologic Colectomies.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Same author

Pulsed Low-Dose-Rate Chemoradiation Induces Stromal Reprogramming in Pancreatic CAF-Generated ECM: Quantification by the HOST-Factor.

Gastro hep advances·2026

Same author

Neoadjuvant radiotherapy for primary retroperitoneal well-differentiated liposarcoma: a Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) propensity score matched analysis.

EClinicalMedicine·2026

Same author

The role of regional nodal irradiation in clinically node-positive breast cancer patients who undergo neoadjuvant chemotherapy and breast-conserving surgery.

Breast cancer research and treatment·2026

Same journal

Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026

Same journal

Beyond the Scalpel's Reach.

The Surgical clinics of North America·2026

Same journal

Stepwise Solutions-Society.

The Surgical clinics of North America·2026

Same journal

Stepwise Solutions-Hospitals.

The Surgical clinics of North America·2026

Same journal

Stepwise Solutions for Providers.

The Surgical clinics of North America·2026

Same journal

Stepwise Solutions-Patients Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 16, 2026

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

Retroperitoneal Sarcomas.

Andrea S Porpiglia¹, Sanjay S Reddy², Jeffrey M Farma²

¹Crozer Keystone Health Network, Department of Surgery, 2100 Keystone Ave, Drexell Hill, PA 19026, USA.

The Surgical Clinics of North America

|August 21, 2016

Summary

This summary is machine-generated.

Retroperitoneal sarcomas are rare cancers. Surgical removal with clear margins is the primary treatment, but it is difficult due to late diagnosis and proximity to other organs.

Keywords:

Chemotherapy Radiation Retroperitoneal liposarcoma Retroperitoneal sarcoma Surgery

More Related Videos

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

Related Experiment Videos

Last Updated: Mar 16, 2026

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

Area of Science:

Oncology
Surgical Oncology
Medical Oncology

Background:

Retroperitoneal sarcomas are uncommon malignancies, accounting for 15% of all sarcomas.
These tumors often present late, complicating treatment.
Involvement of adjacent structures poses significant surgical challenges.

Purpose of the Study:

To summarize the current understanding and management of retroperitoneal sarcomas.
To highlight the challenges in surgical resection.
To emphasize the importance of a multidisciplinary approach.

Main Methods:

Review of existing literature on retroperitoneal sarcomas.
Analysis of treatment strategies, including surgery, radiation, and chemotherapy.
Discussion of diagnostic and therapeutic challenges.

Main Results:

Surgical resection with negative margins is the cornerstone of treatment.
Late presentation and adherence to adjacent structures frequently impede complete resection.
Adjuvant therapies like radiation and chemotherapy require careful consideration.

Conclusions:

Complete surgical resection is crucial for favorable outcomes in retroperitoneal sarcomas.
Multidisciplinary team decision-making is essential for optimizing treatment plans.
Tertiary referral centers are vital for managing these complex cases.